Individual state nursing approvals Colibri Healthcare, LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. In addition to states that accept courses offered by ANCC accredited Providers, Colibri Healthcare, LLC is an approved Provider of continuing education in nursing by: Alabama Board of Nursing, Provider #ABNP1418 (valid through February 5, 2025); Arkansas State Board of Nursing, Provider #50-4007; California Board of Registered Nursing, Provider #CEP17480 (valid through January 31, 2024); California Board of Vocational Nursing and Psychiatric Technicians (LVN Provider # V15058, PT Provider #V15020; valid through December 31, 2023); District of Columbia Board of
Nursing, Provider #50-4007; Florida Board of Nursing, Provider #50-4007; Georgia Board of Nursing, Provider #50-4007; Kentucky Board of Nursing, Provider #7-0076 (valid through December 31, 2023; CE Broker provider #50-4007). Michigan Board of Nursing, Provider #50-4007; Mississippi Board of Nursing, Provider #50- 4007; New Mexico Board of Nursing, Provider #50-4007; North Dakota Board of Nursing, Provider #50-4007; South Carolina Board of Nursing, Provider #50-4007; and West Virginia Board of Registered Nurses, Provider #50-4007. This CE program satisfies the Massachusetts States Board’s regulatory requirements as defined in 244 CMR5.00: Continuing Education.
Activity director Shirley Aycock, DNP, RN, Executive Director of Quality and Accreditation Disclosures Resolution of conflict of interest In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/commercial support and non-endorsement It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative
to diagnostic and treatment options of a specific patient’s medical condition.
©2023: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers. Course verification All individuals involved have disclosed that they have no No. 241, every reasonable effort has been made to ensure that the content in this course is balanced and unbiased. significant financial or other conflicts of interest pertaining to this course. Likewise, and in compliance with California Assembly Bill
ASTHMA MANAGEMENT PRINCIPLES AND GUIDELINES
Asthma is a chronic disease characterized by airway inflammation that can be controlled with appropriate interventions, including medications, trigger avoidance, identification of signs and symptoms of worsening asthma, and/or peak flow monitoring (if appropriate). Asthma is a chronic disease. Symptoms of asthma may include wheezing, shortness of breath, chest tightness, and cough. Expiratory airflow limitation may also be experienced by the person with asthma. Airway hyperresponsiveness (AHR), which occurs in response to asthma triggers, is also associated with asthma. Asthma symptoms are not usually persistent; they are intermittent and vary in intensity, which poses challenges to treatment. It needs to be emphasized that AHR and chronic airway inflammation are present even when the person with asthma is not experiencing any asthma symptoms. Although there are several different underlying disease processes of asthma with distinct demographic, clinical, and/or pathophysiological characteristics (referred to as phenotypes), treatment goals remain the same (GINA, 2021). However, accurate diagnosis needs to occur before appropriate asthma interventions can be implemented. Treating asthma before carrying out objective tests decreases their sensitivity and can make confirmation of the diagnosis difficult. Unfortunately, there is no agreed-upon gold standard to diagnose asthma. Asthma may present with common respiratory symptoms, and physical
examination may be unrevealing. Additionally, the most widely available tests (peak flow and spirometry) can be normal unless the patient is experiencing an exacerbation. This may result in underdiagnosis or overdiagnosis of asthma. Overdiagnosis leads to unnecessary treatment and a delay in making an alternative diagnosis. Underdiagnosis risks the continuation of daily symptoms, potentially serious exacerbations, and long- term structural changes in the airway (Kavanagh et al., 2019). A diagnosis is typically made by reviewing clinical features and objective measures and by assessing response to therapy. It needs to be emphasized that asthma management is not a one-size-fits-all endeavor. Interventions need to be individualized at each interaction with the healthcare system according to the level of severity and asthma control. It is crucial that healthcare providers use an evidence-based approach to managing asthma within the population. Treatment decisions need to consider the patient’s likely response to treatment, patient preferences, and practical issues. It is crucial for the healthcare provider to discuss barriers to adherence to the asthma management plan, which may include medication access and cost to the patient (GINA, 2021).
Book Code: ANCCUS2423
EliteLearning.com/Nursing
Page 2
Powered by FlippingBook